Elinogrel, an orally and intravenously available ADP-receptor antagonist How does elinogrel affect a personalized antiplatelet therapy?

Mueller, K. A. L.; Geisler, T.; Gawaz, Meinrad

dc.contributor.author	Müller, Karin Anne Lydia
dc.contributor.author	Geisler, Tobias
dc.contributor.author	Gawaz, Meinrad Paul
dc.date.accessioned	2014-03-17T09:57:18Z
dc.date.available	2014-03-17T09:57:18Z
dc.date.issued	2012
dc.identifier.issn	0720-9355
dc.identifier.uri	http://hdl.handle.net/10900/43580
dc.language.iso	en	de_DE
dc.publisher	Schattauer Gmbh - Verlag Medizin Naturwissenschaften	de_DE
dc.relation.uri	http://dx.doi.org/10.5482/ha-1192	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	Elinogrel, an orally and intravenously available ADP-receptor antagonist How does elinogrel affect a personalized antiplatelet therapy?	de_DE
dc.type	Article	de_DE
utue.quellen.id	20140226071329_01458	de_DE
utue.publikation.seiten	191-194	de_DE
utue.personen.roh	Mueller, K. A. L.
utue.personen.roh	Geisler, T.
utue.personen.roh	Gawaz, Meinrad
dcterms.isPartOf.ZSTitelID	Hamostaseologie	de_DE
dcterms.isPartOf.ZS-Issue	3	de_DE
dcterms.isPartOf.ZS-Volume	32	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE